measuring function in cancer patients: do we need disease- or sarcopenic-specific measures?
Published 6 years ago • 141 plays • Length 24:21Download video MP4
Download video MP3
Similar videos
-
59:39
measurements of aging to use in cancer cohort studies
-
1:03:24
the body composition and cancer outcomes research webinar series: sarcopenia and cancer survival
-
34:20
evidence of the import of sarcopenia and other measures of body composition on cancer survival
-
29:41
measuring body composition/sarcopenia in large studies using anthropometry and bia
-
36:23
the sarcopenic phenotypes: overview and role of body composition quantification methods
-
5:05
how we measure cancer: incidence
-
4:24
how we measure cancer: introduction
-
1:01:00
cancer & aging: biological and phenotypic measures of aging
-
23:41
exercise therapy to improve muscle quantity and quality in cancer survivors
-
16:46
applying what we’ve learned from clinical trials about cachexia to cancer survivors
-
27:28
where are the gaps? what research do we need to inform guidelines and clinicians?
-
5:31
tips - managing fatigue during cancer treatment
-
23:27
different cutpoints/landmarks: finding cutpoints to predict those at risk for poor outcomes
-
1:16
nci minute: smoking and cancer treatment
-
56:55
evaluating the impact of diet and physical activity interventions in cancer survivorship
-
1:05:39
body composition and treatment-related toxicities
-
1:40
dr jessica donington: osteopontin's role in lung cancer detection and prognosis
-
1:00:42
automating body composition from routinely acquired ct images-towards 3d measurements